The recommendations listed in this document are, whenever possible, evidence based. An
extensive review was conducted on literature published through March 1, 2020. Searches …

Aim This executive summary of the valvular heart disease guideline provides
recommendations for clinicians to diagnose and manage valvular heart disease as well as …

Background: Post-market surveillance is needed to evaluate the real-world clinical
effectiveness and safety of US Food and Drug Administration–approved devices. Objectives …

Percutaneous mitral valve repair (PMVR) using the MitraClip System is feasible and entails
clinical improvement even in patients with high surgical risk and severe functional mitral …

Secondary (or functional) mitral regurgitation (SMR) occurs frequently in chronic heart failure
(HF) with reduced left ventricular (LV) ejection fraction, resulting from LV remodelling that …

Objectives This study sought to assess the impact of right ventricular dysfunction (RVD) as
defined by impaired right ventricular-to-pulmonary artery (RV-PA) coupling, on survival after …

Background Among patients with severe functional mitral regurgitation (FMR), atrial
functional mitral regurgitation (aFMR) represents an underrecognized entity. Data regarding …

Systolic heart failure is frequently accompanied by a relevant functional mitral valve
regurgitation (FMR) which develops as a direct sequela of the ongoing left ventricular …

Background: Transcatheter mitral valve (MV) repair with the MitraClip received approval in
2013 for the treatment of prohibitive-risk patients with primary mitral regurgitation (MR) …

Objectives This study sought to evaluate the role of cardiac magnetic resonance (CMR) for
the quantification of ischemic mitral regurgitation (IMR) and myocardial infarct size (MIS) in …